PMCF MOVE®-C International, Prospective, Multicentre, Non-randomised Post-market Clinical Follow-up Study Clinical and Radiological Outcome After Mono- and Bisegmental Cervical Intervertebral Disc Prosthetics
Objectives: Observational study to confirm the safety and performance of the cervical disc prosthesis MOVE®-C.
• Diagnosis of discopathy or disc hernia with radiculopathy or stenosis of the foramen and spinal canal,
• documented individual history of neck and/or upper extremity pain and/or functional/neurological deficit associated with the cervical level to be treated,
• no surgical treatment regarding the planned index surgery within the last six weeks prior implantation,
• unsuccessful conservative medical care regarding the indication within the last six weeks,
• age ≥18 years,
• patient must agree to fully participate in the clinical trial and give informed consent in writing,
• patient is capable to realise the nature, aims and possible consequences of the clinical trial (MPG §20.2.1),
• patient information has been provided and all written consents of the patient are available.